Anti-CD22 CAR NK Cells

· Allife Medical Science and Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-CD22 CAR NK Cells, covering 2019-01-30 to 2019-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of Anti-CD22 CAR NK Cells in Relapsed and Refractory B Cell Lymphoma [EARLY_Phase 1]